Adrenomedullin (AM) could promote the proliferation, the odontogenic differentiation and inhibit the apoptosis of dental pulp stem cells (DPSCs). AM in combination with DPSCs may be an effective strategy for pulp repair. However, there was no report on the mechanisms of AM in the odontogenic differentiation of DPSCs. The aim of this study is to investigate the molecular mechanisms through which AM promotes the odontogenic differentiation of DPSCs. Freshly extracted wisdom teeth were obtained from 27 patients. Cells at passage 3 to passage 5 were used in this study. DPSCs were treated with or without 10 −7 M AM in Dulbecco's modified Eagle's medium culture, and then the accumulated calcium deposition was analyzed after 21 days by using alizarin red S staining. Odontogenic differentiation markers were determined by western blot analysis and quantitative real-time PCR. Western blot analysis results showed that AM had the capability of promoting the odontogenic differentiation of DPSCs and AM could enhance the phosphorylation of CREB and up-regulate the expression of BMP2. H89 is a CREB inhibitor which can inhibit the odontogenic differentiation of DPSCs through inhibiting the phosphorylation of CREB. Noggin could inhibit the odontogenic differentiation of DPSCs through inhibiting the activity of BMP2. These results indicated that AM could promote the odontogenic differentiation of DPSCs by upregulating the expression of BMP2 through the CREB signaling pathway.
Introduction
Human adrenomedullin (AM) which was initially isolated from a human brain pheochromocytoma is a hypotensive peptide consisting of 52 amino acids [1] . AM has recently been shown within the dentine matrix and the expression of AM is enhanced in dental pulpal tissue due to caries [2] . A recent study has shown that AM has multiple effects, including regulation of inflammation, infection, angiogenesis, mineralized-tissue formation and development [3] . AM is expressed within the developing immature teeth and can stimulate hard tissue formation in vivo when stem cells are exposed to mineralizing stimuli, and modulate the effects of transforming growth factor beta1 (TGF-β1) [4] .
The research of dental pulp cells has a long history while that of dental pulp stem cells (DPSCs) is quite new. DPSCs were first isolated from pulp tissue of permanent human teeth in 2000, which were designated as postnatal DPSCs [5] . DPSCs were supposed to play an important role in the repair and regeneration of dental pulpal tissue due to their potent odonto/osteogenic and rapid proliferation capacity [6] . DPSCs are highly proliferative and have the potential to differentiate into several cell types, including odontoblasts, neural progenitors, osteoblasts, chondrocytes, and adipocytes. Therefore, DPSCs are attractive candidates in the area of the dental regeneration owing to their multipotency, high proliferation rate and availability.
AM in combination with DPSCs may be an effective therapeutic strategy for pulp injury. A previous study has shown that AM can promote the proliferation, the odontogenic differentiation and inhibit the apoptosis of DPSCs [7] . Further studies showed that AM promotes the proliferation of DPSCs through activation of the JNK/ c-Jun signaling pathway, and inhibits the apoptosis of DPSCs through activation of the Src/GSK-3β signaling pathway [8] . However, the regulatory mechanism by which AM influences the odontogenic differentiation of DPSCs remains unclear.
Bone morphogenetic proteins (BMPs) are related to the tooth development, and the expression of BMP2 was found to be increased during the terminal differentiation of odontoblasts [9] . A previous study has shown that BMP2 may regulate the differentiation of pulp cells into odontoblastic lineage and stimulate reparative dentin formation [10] . cAMP-responsive transcription is mediated by members of the CREB/ATF family (CREB, ATF-1, and CREM), and CREB activity is controlled by phosphorylation through multiple signaling pathways [11] . It has been shown that the constitutively phosphorylated transcription factor CREB is involved in the biomineralization process of adult human molar odontoblasts and cementoblasts [12] . Noggin is generally known as an antagonist of BMP2. Noggin has been shown to have a high affinity for BMP binding protein through preventing BMPs from interacting with receptors on the cell surface to inhibit BMP activity [13] . In this study, we investigated whether AM promoted the odontogenic differentiation of DPSCs by regulating the expression of BMP2 through CREB signaling pathway.
Material and Methods

Materials
AM and bovine serum albumin (BSA) were purchased from Sigma (St Louis, USA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), and penicillin-streptomycin were purchased from Gibco (Gaithersburg, USA). Trizol was purchased from Invitrogen (Carlsbad, USA). RNA reverse transcription and quantitative polymerase chain reaction kits were from TaKaRa (Dalian, China). Cell lysis buffer and bicinchoninic acid (BCA) assay kit were purchased from Beyotime Institute of Biotechnology (Haimen, China). Antibodies against β-actin, RUNX2, ALP, OCN, CREB, pCREB and BMP2, and horse radish peroxidase (HRP)-conjugated goat anti-mouse secondary antibody were from Santa Cruz Biotech (Santa Cruz, USA).
Isolation of DPSCs
Freshly extracted wisdom teeth from 27 patients aged 18-25 years were obtained with consent, which was approved by the Medical Ethics Committee of Changhai Hospital. Human primary DPSCs were isolated according to the previously described methods [14] . Briefly, the crown of the tooth is cut just above the cementum junction to open the pulp inclusions. The pulp cells were cleaned by normal saline in the chambers and canals, and DMEM without serum was placed under the cup. Then, the cell suspension was placed in a conical tube and centrifuged at 200 g for 5 min at room temperature. The supernatant was aspirated and the pellet was resuspended in Dispase II-collagenase solution. The solution was left at 37°C for 60 min, and the tube was inverted at 15 min intervals. The suspension was centrifuged at 200 g for 5 min at room temperature. The cell pellet was resuspended in serum-free DMEM and the same volume of DMEM with 20% FBS was added into the cell suspension. The obtained DPSCs were cultured in DMEM containing 10% (v/v) FBS, 1% (v/v) penicillin-streptomycin at 37°C in 5% CO 2 .
Cell culture and AM treatment
Human primary DPSCs were cultured in DMEM containing 10% FBS and 1% penicillin-streptomycin in an incubator at 37°C with 5% CO 2 . The culture medium was changed every 3 days until the primary DPSCs reached 80% confluency. Then, the cells were passaged for expansion. Only cells at the early passages were used in this study. Cells treated with or without 10 −7 M AM were defined as the experimental group and the control group, respectively.
Alizarin red S staining
Confluent cultures of DPSCs were induced to undergo mineralization by supplementing the growth medium mentioned above with 50 μg/ml ascorbic acid, 10 mM β-glycerophosphate, and 100 nM dexamethasone [15] . The mineralization induction medium was changed every 2 days. The accumulated calcium deposition after 21 days was analyzed by alizarin red S staining as reported previously [15] . In brief, the cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) for 30 min, and after gentle rinse with phosphatebuffered saline (PBS), the cells were incubated with 1% alizarin red S (Sigma-Aldrich) at pH 4.0 for 15 min at room temperature on an orbital shaker (25 rpm). After the cells were washed with PBS, the mineralization nodules were taken under a light microscope. To quantify the stained mineralization nodules, samples were immersed in 2 ml of 10% cetylpyridinium chloride for 15 min at room temperature. The absorbance was measured at the wavelength of 562 nm using a microplate spectrophotometer (Bio Tek, Winooski, USA). Each sample was measured in triplicate.
Western blot analysis
DPSCs were cultured in the presence or absence of 10 −7 M AM for 48 h [16, 17] , and then the cells were collected and lysed with lysis buffer. Protein concentration was determined by BCA assay. Equal amount of protein samples (20 μg) was subject to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then blotted onto a polyvinylidene fluoride membrane using semi-dry method. After being blocked with 5% BSA for 2 h, membranes were incubated with mouse primary antibodies (1:500) against human β-actin, RUNX2, ALP, OCN, CREB, pCREB and BMP2 overnight at 4°C. After three times of wash in Tris-buffered saline with Tween 20, membranes were incubated with HRP-conjugated goat anti-mouse immunoglobulin (IgG) secondary antibody for 2 h at room temperature. Finally, the protein blots were detected by using the ECL Plus Western Blotting Detection System (GE Healthcare, Wisconsin, USA). The molecular weights of protein RUNX2, ALP, OCN, BMP2, and CREB/pCREB are 51, 58, 11, 45, and 35 kDa, respectively. The immunoreactive bands were quantified by LabWork 4.0 image analysis software (UVP, Upland, USA), and protein expression levels were normalized to that of β-actin. All western blot analyses were repeated three times under the same conditions.
Quantitative real-time PCR assay
The odontogenic differentiation marker of BMP2 was detected by real-time polymerase chain reaction (PCR). Total RNA was isolated from DPSCs cultured with or without 10 −7 M AM for 48 h using Trizol reagent according to manufacturer's instructions, and was then reversed transcribed into complementary DNA (cDNA) using a PrimeScript 1stStrand cDNA Synthesis kit (TaKaRa). The gene expression level was measured by a Bio-Rad real-time PCR system (Bio-Rad, Hercules, USA) using a real-time PCR kit (SYBR Premix EX Taq; TaKaRa). mRNA levels were normalized to glyceraldehyde-3-phosphatedehydrogenase (GAPDH) using the comparative cycle threshold (CT) method. The primer sequences are as follows: BMP2 forward: 5′-ACTACCAGAAACGAGTGGGAA-3′, BMP2 reverse: 5′-GCATCTGTTCTCGGAAAACCT-3′; and GAPDH forward: 5′-CTGGGCTACACTGAGCACC-3′, GAPDH reverse: 5′-AGTGG TCGTTGAGGGCAATG-3′. All experiments were performed in triplicate.
Promoter reporter assay
The human BMP2 promoter sequence was designed based on Homo sapiens chromosome 20, GRCh38.p2 Primary Assembly (GenBank accession number NC_000,020.11). Different regions of the hBMP2 promoter (-1978+351, -1699+351, -1396+351, -1094 +351, -669+351, and -297+351) were amplified and cloned into pGL-Luc to construct the recombinant Luciferase expression plasmids pBMP2-Pro-Luc, respectively. DPSCs were cotransfected with 0.5 μg pBMP2-Pro-Luc and 0.5 μg pcDNA-CREB by Lipofectamine 2000. The cells were cultured for 48 h and lysed with Reporter Lysis Buffer (Promega, Madison, USA), and then Luciferase activities of cell lysates were determined by a Luciferase reporter assay kit (Promega) and normalized to β-gal activity.
Chromatin immunoprecipitation assay
The chromatin immunoprecipitation (ChIP) assay was performed using the EpiQuik Chromatin immunoprecipitation kit (Epigentek, Farmingdale, USA). Twenty-four hours after being transfected with AM, the DPSCs were collected and lysed. The immunoprecipitating antibody was mouse anti-human CREB antibody (ab31387; Abcam Scientific, Cambridge, UK). For the negative control, normal mouse IgG provided in the kit was used.
Statistical analysis
Data were analyzed using SPSS 15.0, and t-test was used to analyze significant difference between the control and tested group. Data were presented as the mean ± standard deviation. Five independent experiments were carried out and at least 5 samples per test were taken for statistical analysis. P < 0.05 (*) and P < 0.01 (**) were considered to be statistically significant and extremely significant, respectively.
Results
AM promotes the differentiation of DPSCs into odontoblasts
DPSCs were treated with 10 −7 M AM and cultured in odontoblasts differentiation induction medium for 21 days, followed by alizarin red S staining assay. The results showed that the staining level of DPSCs treated with AM is significantly higher than that of the control group (Fig. 1A) . DPSCs were treated with 10 −7 M AM and then cultured in common medium for 48 h. Then, the expressions of odontoblast differentiation-related marker proteins, i.e. RUNX2/ALP/OCN were determined by western blot analysis. The expression levels of Runx2/ALP/OCN proteins appeared to be remarkably higher in the AM-treated group compared with those in the control group (Fig. 1B-D) , implied that AM could promote the differentiation of DPSCs into odontoblasts.
AM promotes the phosphorylation of CREB and the expression of BMP2
DPSCs were treated with 10 −7 M AM and cultured in common medium for 48 h. Then, the expressions of CREB and pCREB were determined by western blot analysis and the mRNA expression of BMP2 was determined by qPCR. The results indicated that the pCREB expression level of the AM-treated group was significantly increased compared with the control group, while the CREB level showed little difference between the two groups ( Fig. 2A,B) . qPCR and western blot analysis results showed that a significant increase of BMP2 at both the mRNA level and protein level in the AMtreated group compared with those of the control group (Fig. 2C,D) . These results suggested that AM could upregulate BMP2 expression by promoting the phosphorylation of CREB.
CREB transcription regulates the expression of BMP2
Different regions (-1978+351, -1699+351, -1396+351, -1094 +351, -669+351, and -297+351) of the hBMP2 promoter were cloned to construct the recombinant Luciferase expression plasmids, respectively, and then cotransfected into DPSCs with CREB expressing recombinant plasmid pcDNA-CREB. The BMP2 promoter activity was monitored by Luciferase activity reporting assay. The results showed that the relative Luciferase activities of four fragments, -1978+351, -1699+351, -1396+351, and -1094+351, are undistinguishable from the control, whereas the activities of fragments -669+351 and -297+351 are significantly reduced compared with the control (Fig. 3A) , suggesting that the CREB recognition site is located in the region between -1979 and -669 in the BMP2 promoter. ChIP assay was used to determine the binding site of CREB to the BMP2 promoter. The result indicated that CREB binds to the region between -1094 and -669 of BMP2 gene (Fig. 3B) . All these results suggested that CREB can promote BMP2 transcription and expression by binding to the region between -1094 and -669 of the BMP2 promoter.
H89 inhibits the phosphorylation of CREB
DPSCs were treated with 10 −7 M AM plus 5 μM H89, and DPSCs treated with 10 −7 M AM only were used as the control. These two groups of cells were cultured in common medium for 48 h. Then, the expressions of CREB/pCREB/BMP2/RUNX2/ALP/OCN were detected by western blot analysis. Results in Fig. 4A showed that there was little difference in the CREB expression level between the two groups. In contrast, the expression levels of pCREB/BMP2/ RUNX2/ALP/OCN were significantly lower in cells treated with both AM and H89 compared with those in cells treated with AM only (Fig. 4B-F) . These results suggested that H89 could inhibit the promoting effects of AM on DPSCs odontoblast differentiation by inhibiting the phosphorylation of CREM and the expression of BMP2.
Noggin inhibits the activity of BMP2
DPSCs were treated with 10 −7 M AM in combination with 100 ng/ml Noggin, and DPSCs treated with 10 −7 M AM only served as the control.
The treated DPSCs of the two groups were then cultured in common medium for 48 h. Then, the expressions of CREB/pCREB/BMP2/ RUNX2/ALP/OCN were determined by western blot analysis. The results showed that there was no significant difference in CREB/pCREB/ BMP2 expression levels between these two groups ( Fig. 5A-C) , and the expression levels of RUNX2/ALP/OCN in the group treated with 10 −7 M AM + 100 ng/ml Noggin were lower than those of the control group ( Fig. 5D-F) . These results suggested that Noggin did not affect the promoting activity of AM in the phosphorylation of CREB and the expression of BMP2; however, Noggin could inhibit the promoting effect of AM on the odontogenic differentiation of DPSCs through inhibiting the activity of BMP2. 
Discussion
The control of odontogenic differentiation of DPSCs has great potential in the application of oral regenerative medicine and cytology treatment [18] . Many signal pathways could control the odontogenic differentiation of DPSCs and AM is believed to have relationship with many types of stem cells and progenitor cells. Previous studies have shown that AM has regulating effect on the differentiation of some specific stem cells [19] . AM has multi-effects, such as regulating cell proliferation and differentiation through autocrine and paracrine way [19] [20] [21] [22] [23] . AM has great regulating effects on many kinds of stem cells, including endothelial progenitor cells, mesenchymal stem cells, hematopoietic stem cells, adrenocortical stem cells, and neural stem/progenitor cells [21, 24, 25] . Previous studies has also shown that AM could promote the proliferation of DPSCs through activation of the JNK/c-Jun signaling pathway and inhibit the apoptosis of DPSCs through activation of the Src/GSK-3β signaling pathway [8] . However, there has been few research on the odontogenic differentiation of DPSCs.
In the present study, DPSCs were treated with 10 −7 M AM and the expressions of the marker proteins RUNX2/ALP/OCN of the odontogenic differentiation of DPSCs were determined by western blot analysis. The results showed that the expressions of these marker proteins were significantly higher in the treated group than those in the control group, suggesting that AM could promote odontogenic differentiation of DPSCs.
It has been shown that CREB is crucial to the osteogenesis of embryos and adults, and that CREB performs its function by upregulating the transcription of BMP2 in osteoblast cells [26] . The transcription factor CREB has been found to play an important role in osteogenesis. It regulates the synthesis and metabolism of bones by adjusting the expression of the osteogenic marker gene of osteoblast cells [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . Previous in vivo studies have provided evidence for the metabolism of CREB in bones [26, 37, 38] . A recent report implied that the small molecules with osteogenesis activity could induce the differentiation of osteoblast cells by activating CREB in the cells [39] . BMPs belong to the TGF-β superfamily 16. Members of this family have similar structures and multiple functions. BMPs were initially identified as the regulatory protein of chondrogenesis and osteogenesis, which participates in embryo development and the formation of many organs and tissues including teeth [40] . The role of BMPs is being more and more recognized in the regeneration of teeth and dentin [41] [42] [43] [44] [45] . BMPs can induce cell proliferation, collagen synthesis, ALP activity and osteocalcin synthesis in osteoblast cells. The function of BMP2 in human dental pulp is to regulate the expression of the molecular markers in odontoblasts, such as ALP [46, 47] , DSPP, dentin matrix protein 1, and Nestin. BMP2 also plays an important role in inducing the differentiation of odontoblastand and in stimulating the formation of dentin-pulp complex. It has been shown that BMPs can induce DPSCs differentiation into odontoblast-like cells and significantly increase the activity of odontoblast differentiation marker [9, 48] . Likewise, CREB may have the same function in dentin matrix. Our study about whether AM regulates BMP2 expression to promote the differentiation of DPSCs into odontoblast-like cells through CREB signal pathway is based on this assumption.
H89 has an inhibitory effect on CREB activity [49] . Therefore, our results implied that H89 could inhibit the promoting effect of AM on DPSCs differentiation into odontoblast-like cells, which was achieved by inhibiting CREB phosphorylation and BMP2 expression. In the process of bone healing, high concentration of BMP2 is applied because the presence of BMP antagonist, such as Noggin, can remarkably reduce the treatment effect [50] . Our results implied that Noggin could inhibit the promoting effect of AM on DPSCs differentiation into odontoblast-like cells, which was achieved by inhibiting BMP2 activation. Based on these results, we proved that the promoting effect of AM on the differentiation of DPSCs into odontoblast-like cells was achieved by regulating BPM2 expression through CREB signal pathway.
In summary, we demonstrated that AM has the ability to promote the odontogenic differentiation of DPSCs and that AM enhances the phosphorylation of CREB and upregulates the expression of BMP2. H89 is a CREB inhibitor which can inhibit the odontogenic differentiation of DPSCs through inhibiting the phosphorylation of CREB. Noggin inhibits the odontogenic differentiation of DPSCs through inhibiting the activity of BMP2. Therefore, AM may promote the odontogenic differentiation of DPSCs by upregulating the expression of BMP2 through the CREB signaling pathway.
